Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according ...

The Fellows of the AACR Academy have elected Elaine V. Fuchs, PhD, FAACR, as their next President. She will assume the ...

Dr. Kevin Kalinsky discusses the role of targeted therapy and clinical decision-making in managing estrogen-driven, ...

Leiden, the Netherlands, March 13, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents its preliminary (unaudited) financial report for the ...

The dedication of these charities, set up when a family has been touched by cancer, drives forward our research immeasurably. We are so grateful to work with such passionate organisations and receive ...

OnKure's drug candidate pipeline is highlighted by OKI-219, a selective PI3K alpha H1047R inhibitor for the treatment of certain types of breast cancer that began clinical trials in February 2024.

ELF4, a transcription factor belonging to the ETS family, has emerged as a pivotal regulator in cell differentiation, immune system function, and cancer progression. This newly published review ...

NEW BRIGHTON, Minn. (WCCO) – A 20-year-old Minnesota man died while embarking on a family trip as part of his final wish. His family spoke about his lasting legacy. Twenty-year-old Giacomo ...

YONKERS, N.Y. (PIX11) — A missing New York City woman was found dead in a suitcase Thursday, her family confirmed with NewsNation local affiliate PIX11 News. Pamela Alcantara, 26, was last seen at her ...

Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...

New additions are indicated with an asterisk. The selection of family films on Amazon Prime’s streaming service leaves a little something to be desired, but that just makes a guide like this ...

Doctors recommend protecting your skin while on these medications to lower this risk. PI3K is another protein involved in signaling pathways that control the growth of CLL cells. Different PI3K ...